# Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma

> **NCT00006009** · PHASE1 · COMPLETED · sponsor: **Stanford University**

## Conditions studied

- Lymphoma
- Small Intestine Cancer

## Interventions

- **BIOLOGICAL:** visilizumab

## Key facts

- **NCT ID:** NCT00006009
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2003-10
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006009, "Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00006009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*